MSMarina Vasilievna Shirmankina

Marina Vasilievna Shirmankina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marina Vasilievna Shirmankina has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Experience with a Genetically Engineering Biological Agent in a Child with Hypereosinophilic Syndrome Following Coronavirus Infection: Literature Review and Case Report

    by Larisa A. Balykova, Anna V. Krasnopolskaya, Veronika S. Vereshchagina, Marina V. Shirmankina, Olga Yu. Pigacheva, Anna A. Stradina, Svetlana A. Ledyaykina

    Hypereosinophilic syndrome (HES) is a heterogeneous group of disorders characterized by tissue eosinophilic infiltration and a wide spectrum of clinical manifestations. The issue of pathogenetic therapy for this condition remains unresolved, as some patients are refractory to conventional treatment. Case report . This article discusses the main challenges of differential diagnosis and current approaches to the treatment of HES in pediatric practice, and presents a rare clinical case of primary HES in a 14yearold girl. After a thorough diagnostic workup and confirmation of the diagnosis, the patient received systemic glucocorticoid therapy, which produced a temporary effect. However, due to the development of a severe exacerbation upon attempted withdrawal of hormonal therapy, treatment with mepolizumab — a humanized monoclonal antibody against the interleukin5 receptor — was initiated. Conclusion . The management of patients with HES often presents significant difficulties due to the polymorphism of clinical manifestations, the need to rule out a wide range of diseases, and possible refractoriness to standard therapy. The usage of this genetically engineered biological agent demonstrated high efficacy, enabling the patient to overcome glucocorticoid dependence and prevent the development of glucocorticoid-related adverse effects.

  • Open Access

    Diagnostic and pharmacological correction of cardiovascular system changes in children, adolescents, and young adults with long COVID: comparative randomized clinical trial in parallel groups

    by L. A. Balykova, M. V. Shirmankina, A. V. Krasnopolskaya, A. A. Stradina, S. A. Ivyansky, T. M. Duvayarova, D. S. Rodionov

    The aim. To evaluate the effectiveness of L-carnitine in the complex correction of cardiovascular and autonomic manifestations of long COVID in children, adolescents, and young adults.Materials and methods. Within the framework of an open, simple, randomized, parallel-group comparative clinical study, the effectiveness of L-carnitine at a dose of 50–75 mg/kg per day in 2 doses for 6 weeks in addition to standard therapy in children and adolescents aged 10 to 17 years, as well as young people aged 18–25 years with long COVID (n = 45) was studied in comparison with the standard therapy (n = 45) using clinical and anamnestic, electrophysiological, echocardiographic and other methods. The statistical processing of the results was carried out by the variational method, and correlation and regression analysis using Student’s t-test for dependent samples, as well as the McNemar chi-square test.Results. The most frequent clinical manifestations of long COVID were: high fatigue, headaches and muscle weakness — in 66.7–100%. After 6 weeks of treatment, the absence of complaints and normalization of objective status were noted in 93.3% of patients in the main group and 66.7% in the comparison group (p < 0.05). Repolarization abnormalities and rhythm disturbances, initially registered in 43.3% of patients, were not observed after 6 weeks of therapy in the main group, while they persisted in more than 50% in the comparison group. By the 6 weeks of treatment, there were no changes in Echo in the main group, while in the comparison group (slight dilatation of the left ventricle) persisted in 9 out of 12 patients. In the main group, according to Holter monitoring, restoration of heart rate, normalization of its autonomic regulation, reduction in the representation of bradyarrhythmias and “density” of extrasystoles were achieved.Conclusion. The effectiveness of L-carnitine for the correction of the frequency and severity of autonomic and cardiac disorders in the subjects with long COVID has been shown.

  • Open Access

    “Muscle Bridge” as a Possible Risk Factor for Sudden Cardiac Death in a Child with Hypertrophic Cardiomyopathy: Case Study

    by Larisa A. Balykova, Irina V. Leontyeva, Irina M. Miklashevich, Sergey A. Thermosesov, Anna V. Krasnopolskaya, Marina V. Shirmankina, Natalya V. Shchekina, Yuliya S. Isaeva, Pavel A. Shkurin

    Background. Hypertrophic cardiomyopathy (HCM) is one of the most common causes of sudden cardiac death (SCD) in young adults under the age of 35. SCD may be the first and only clinical manifestation of the disease in children. Case presentation. Female patient with HCM and low risk of cardiac events suffered the first episode of SCD associated with physical activity at the age of 12 years 4 months. Acute myocardial ischemia was suspected due to abnormal coronary arteries, “muscle bridge”, that was the trigger of malignant ventricular arrhythmias leading to cardiac arrest. Implantable cardioverter defibrillator (ICD) was installed for secondary SCD prevention. However, the disease has progressed, and the child suffered two more episodes due to ventricular fibrillation, managed by ICD and resuscitation measures. Drug therapy and ICD regimens were adjusted. Myocardial revascularization was not performed due to high surgical risk. Conclusion. Difficulties in management of patient with HCM complicated with acute myocardial ischemia due to congenital coronary arteries anomaly are presented. Myocardial ischemia is not considered as “large” risk factor for SCD in children (according to traditional evaluation). However, it can be a trigger for life-threatening ventricular arrhythmias and negatively affect HCM prognosis as it has been shown in our observation.

  • Open Access

    The Impact of Noise Exposure on Psychophysiological Parameters in Students

    by Natalya N. Chernova, Oksana P. Balykova, Ludmila I. Kitaeva, Marina V. Shirmankina

    Introduction. Currently, noise is regarded not only as a harmful occupational factor but also as a significant physical element of the living environment, constituting an integral part of human life. The aim of this study is to determine noise exposure levels in higher education institutions and assess its impact on the psychophysiological parameters of students. Materials and methods. The annual noise exposure was calculated using measurements obtained from the "Assistant" noise and vibration analyzer. To assess the impact of noise on the psychophysiological parameters of students, the Münsterberg method was employed, along with a stress-level monitoring system and pure-tone threshold audiometry, including investigations of air and bone conduction within the standard frequency range. This study does not require approval from a biomedical ethics committee. Results. It was established that during daytime hours, noise levels across the campus of National Research Mordovia State University and building interiors (hallways, restrooms, and cloakrooms) remind with permissible limits. However, elevated noise levels were recorded in lecture halls. Based on the obtained measurements and questionnaire results, a risk group was identified, showing a statistically significant reduction in selective attention at a noise level of 65.5 dBA. The study is limited to examining the subjective parameters of noise impact on students at the Medical Institute. An evaluation of 97 questionnaires from 1st to 6th-year students was conducted, representing a sufficiently representative sample. According to the obtained annual noise exposure data, two groups were formed: Group I (n = 10) – individuals with minimal noise exposure (annual noise exposure ranging from 62.5 to 68.2 dBA), and Group II (n = 10) – the risk group (annual noise exposure ranging from 80.1 to 85.6 dBA). A comparative assessment of cognitive functions was performed in the risk group using the Münsterberg method, along with an evaluation of psychophysiological parameters using a stress-level control system. Discussion and conclusion. The evaluation of certain cognitive indicators confirms the nonspecific effect of noise on students, manifesting as reduced selectivity and concentration of attention, as well as a decline in all parameters of the nervous system's functional capabilities, which has been identified among at-risk students.

  • Open Access

    Hypereosinophilic Syndrome: Contemporary Approaches to Molecular-Genetic Diagnostics and Gene-Engineered Biologic Therapy

    by Larisa Aleksandrovna Balykova, Anna Valerievna Krasnopolskaya, Marina Vasilievna Shirmankina, Diva Augusta Tavares Mendes, Anastasia M. Khanina, Ханина Анастасия Михайловна

    Introduction. In recent years, there has been a growing interest among researchers in conditions associated with hypereosinophilia and the therapeutic potential of genetically engineered biological agents. Hypereosinophilic syndrome remains an insufficiently studied issue encompassing a spectrum of disorders characterized by persistent eosinophilia and eosinophilic involvement of internal organs. The aim of this study is to systematize scientific literature data on novel diagnostic and treatment approaches for hypereosinophilic syndrome.Materials and methods. A comprehensive analysis was conducted on research publications selected based on the keywords “hypereosinophilia”, “hypereosinophilic syndrome”, “molecular-genetic studies”, “idiopathic hypereosinophilic syndrome” and “monoclonal antibody” from a cohort of full-text articles available in the electronic scientific databases eLibrary, PubMed, and Scopus between 2005 and 2024.Results. The hypereosinophilic syndrome is a rare condition, with a limited number of scientific observations available in the literature, primarily consisting of analyses of individual clinical cases. Data on the prevalence of hypereosinophilic syndrome in the pediatric population are extremely scarce. The causes of the syndrome are variable, and the clinical presentation is polymorphic, complicating the diagnostic process. Molecular-genetic research, including the detection of tyrosine kinase gene mutation types, contributes to solving this issue. First-line treatment involves glucocorticosteroids. It has been shown that genetically engineered biological agents are more effective in the treatment of primary hypereosinophilic syndrome, with their pathogenetically justified use associated with therapeutic progress.Discussion and conclusion. The hypereosinophilic syndrome is more commonly observed in young and middle-aged patients. Diagnostic criteria include persistent hypereosinophilia with organ damage or dysfunction, as well as the exclusion of other myeloid neoplasms. The use of genetically engineered biologic agents enables overcoming refractoriness, reducing the need for glucocorticosteroids, and preventing the development of drug-related complications.


  • Open Access

    Electrical instability of the myocardium in children of different ages: diagnosis, prognostic significance and principles of correction (literature review)

    by Larisa A. Balykova, Denis O. Vladimirov, Evgenia N. Tyagusheva, Marina V. Shirmankina, Anna V. Krasnopolskaya, Elena I. Naumenko

    Varying degrees of risk of life-threatening conditions. Today, the problem of diagnosis and clinical interpretation of EIM in newborns is particularly acute due to anatomical and physiological features and comorbid conditions, as well as in children and adolescents with organic heart diseases. Studying the heterogeneity of electrocardiographic (ECG) morphology of cardiac cycles may have prognostic value for the prevention of arrhythmic events. The article provides an overview of modern scientific data on the signs of EIM in children, including the newborn period, formed into two large groups: depolarization and repolarization disorders. ECG criteria for EIM in children of different ages with congenital (primary) electrical diseases and acquired conditions, including COVID-19, are discussed. The methods of medical correction of ENM in newborns and children in subsequent age periods are highlighted. The totality of the data presented dictates the need for further study of the prognostic significance of EIM and methods of its correction.


  • Syncope in children and adolescents in sports medicine

    by L. A. Balykova, S. A. Ivyanskiy, Yu. O. Soldatov, T. S. Shablinova, M. V. Shirmankina, T. M. Duvayarova, D. V. Durnaikina, Yu. S. Shabunina

    The clinical case of a neuro-mediated syncope episode in a sports-active adolescent is presented. The differential diagnosis included the following conditions: cardiomyopathy induced by physical factors, sinus node dysfunction, and sinus node weakness syndrome. After conducting necessary laboratory and instrumental investigations (ECG, echocardiography, 24-hour ECG monitoring, and exercise stress test), these conditions were excluded. The patient was discharged to outpatient care with recommendations for non-pharmacological syncope prevention.

  • Open Access

    Electrical Instability of the Myocardium in Children and Adolescents

    by Larisa A. Balykova, Marina V. Shirmankina, Stanislav A. Ivyanskiy, Anna V. Krasnopolskaya, Denis O. Vladimirov, Tatyana S. Shablinova, Evgenia N. Tyagusheva, Тягушева Евгения Николаевна

    Currently, there is no doubt that the problem of electrical instability of the myocardium in pediatric cardiology is relevant. The determination of various indicators of electrical instability of the myocardium, which are predictors of life-threatening rhythm disorders and sudden cardiac death, presents an underdeveloped task not only for functional diagnostics specialists, but also for pediatricians, neonatologists, pediatric cardiologists and doctors of other specialties. Non-invasive research methods such as electrocardiography (ECG), Holter ECG monitoring (HM ECG), available in almost all pediatric treatment and prevention institutions, are quite informative in terms of detecting electrophysiological heterogeneity of the myocardium as a predictor of sudden cardiac death, which is especially important in children at risk, as well as young athletes. Thus, the determination of indicators of electrical instability of the myocardium is of great interest, it is a promising direction in modern clinical practice, allowing to predict the risk of developing fatal arrhythmias in children and adolescents.


  • ANCA-associated vasculitis with recurrent thrombosis in a teenager after the new coronavirus infection

    by L. A. Balykova, O. M. Soldatov, Т. И. Раздолькина, V. S. Vereshchagina, M. V. Shirmankina, A. V. Krasnopolskaya, E. F. Moskovskaya

    ANCA-associated vasculitis is a rare disease in children characterized by multiple organ involvement. In recent years, there has been found a connection between systemic vasculitis, including ANCA-associated, and the new coronavirus infection. There are certain difficulties in the differential diagnosis of these conditions. In addition, patients with ANCA-associated vasculitis have a high incidence of venous thromboembolic complications, which creates additional difficulties in the diagnosis and treatment of this disease, especially in children. The article presents the current data review and a clinical case of ANCA-associated systemic vasculitis with damage to the kidneys, lungs, joints (microscopic polyangiitis) in a 17-year-old teenager after the coronavirus infection.


  • Syncopes in adolescents in sport

    by Tatyana S. Shablinova, Marina V. Shirmankina, Anastasia S. Tyurina, Olga Yu. Pigacheva, Elena I. Naumenko, Stanislav A. Ivyanskiy, Larisa A. Balykova, Тюрина Анастасия Сергеевна

    The study analyzes current data on syncope in children and adolescents. The study presents the classification of syncope and briefly describes the clinical manifestations of neurally mediated syncope and the main methods of its diagnosis and treatment. Syncopes associated with organic cardiac pathologies and primary cardiac arrhythmias are caused by hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, coronary artery anomalies, primary long QT syndrome, WolffParkinsonWhite syndrome, and bradyarrhythmias. The diagnostic features of syncope in children and young athletes and modern approaches to treatment and prevention are discussed. Although most syncopes in athletes are not associated with physical activity and have a neurotransmitter genesis, a thorough medical examination is needed. Factors that induce the development of syncopes in athletes must be identified. A prerequisite for admission to sports is the exclusion of the cardiac and arrhythmogenic reasons of syncopes. The decision to expand the sports regime should be made only after a thorough collection of medical history, including family history, and a comprehensive examination. In addition, the degree of risk in view of injuries, provocation, or fatal events following the loss of consciousness during sports must be estimated. This is extremely relevant for sports such as swimming, complex coordination sports (gymnastics and acrobatics), auto and motor sports, and alpine skiing. Although syncopes are common problems in pediatric practice, with only a few cases with cardiac causes based on structural or primary electrical myocardial diseases, they pose the greatest danger in sports medicine. Thus, such conditions must be excluded in young athletes because sports load can aggravate cardiac pathologies, which cause syncopes, due to untimely diagnosis before the start of a sports career.